Cyclophosphamide Tablets IP

Cyclophosphamide Tablets IP

Indications :

Malignant Disease :

• Malignant lymphomas (Stages III and IV of the Ann Arbor staging system).

• Non-Malignant Disease : Biopsy proven minimal change nephrotic syndrome in children

• Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), Mixed-cell type lymphoma.

• Histiocytic lymphoma.

• Burkitt's lymphoma.

• Multiple myeloma.

• Mycosis Fungoides

Dosage :
ADULTS AND CHILDREN :

General Oral Dosage : 400mg/m2 once daily for 5 days.

Dosage Adjustment :
Renal Impairment : Required
Hepatic Impairment : Not required

We are also dealing in: